Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Manion JD: Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation Vol. 95: 1242-1246, 1997.

Konkle BA, Bauer TL, Arepally G, Cines DB, Poncz M, McNulty S, Edie RN, Mannion JD: Heparin-Induced Thrombocytopenia: Bovine versus porcine heparin in cardiopulmonary bypass surgery. Ann Thor Surg Vol. 71: 1920-1924, 2001.

Konkle BA, Nelson C, Forsyth A, Hume E: Approaches to successful total knee replacement in hemophilia A patient with inhibitors. Haemophilia Vol. 8: 706-710, 2002.

Konkle BA, Bauer KA, Weinstein R, Greist A, Holmes HE, Bonfiglio J: Use of recombinant antithrombin (AT) in patients with congenital AT deficiency undergoing surgical procedures. Transfusion Vol. 43: 390-394, 2003.

Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nature Med 2006;12:342-347.

Melendez-Morales L, Konkle BA, Preiss L, Zhang M, Mathew P, Eyster ME, Goedert JJ. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia. AIDS 2006, 21:1631-1636.

Blomback M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R. ISTH SSC Subcommittee on Women’s Health Issues. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost. 2007;5:855-858.

Konkle BA, Ebbesen LS, Erhardtsen E, Bianco RP, Lissitchkov T, Rusen L, Serban MA. Randomized, prospective clinical trial of rFVIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost 2007; 5:1904-1913.

Hoots K, Ebbesen L, Konkle B, Auerswald G, Roberts H, Weatherall J, Ferran J-M, Ljung, on behalf of the NovoSeven (F7HAEM-1505) Investigators: Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life (HRQoL) of haemophilia patients with inhibitors. Haemophilia 2008, 14: 466-475.

Shihong I, Morris D, Konkle BA. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Haemophilia 2009, 15:131-134.

Cuker A, Ptashkin B, Konkle BA, Pipe SW, Whinna HC, Zheng XL, Cines DB, Pollak ES. Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor XA-correlated partial thromboplastin time. J Thromb Haemost 2009, 7:80-86.

Metjian A, Wang C, Sood S, Cuker A, Peterson S, Soucie J, Konkle BA. Bleeding Symptoms and Laboratory Correlation in Patients with Severe von Willebrand Disease. Haemophilia 2009, 15: 918-925.

James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, Kamphuisen PW, Konkle BA, Martinez-Perez O, McLintock C, Peyvandi F, Winikoff R. Von Willebrand disease and other bleeding disorders in women: Consensus on diagnosis and management form an international expert panel. Am J Obstetrics and Gynecology 2009, 201: 12.el-8.

Rauova L, Arepally G, McKenzie SE, Konkle BA, Cines DB, Poncz M. Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia J Thromb Haemost 2009;7(Suppl 1):249-522.

Konkle BA, Kessler C, Aledort L, Andersen J, Fogarty P, Kouides P, Quon D, Ragni M, Zakarija A, Ewenstein B. Emerging clinical concerns in the ageing haemophilia patient. Haemophilia Epub 2009.